Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Misconceptions about calcimimetics.

E F Nemeth1

  • 1NPS Pharmaceuticals, Inc., 101 College Street, South Tower, Suite 800, Toronto, ON M5G 1L8 Canada. enemeth@npsp.com

Annals of the New York Academy of Sciences
|July 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures.

Calcified tissue international·2015
Same author

Allosteric modulators of the extracellular calcium receptor.

Drug discovery today. Technologies·2013
Same author

Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis.

Kidney international·2007
Same author

The parathyroid polyhormone hypothesis revisited.

Kidney international. Supplement·2006
Same author

Summary--calcium receptors: potential targets for novel treatments for skeletal disease.

Journal of musculoskeletal & neuronal interactions·2005
Same author

Calcimimetic and calcilytic drugs: just for parathyroid cells?

Cell calcium·2004
Same journal

Neural Oscillatory Dynamics in Joint Action: Dissociable Roles of Entrainment and Beta Modulation in Self-Other Integration.

Annals of the New York Academy of Sciences·2026
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
See all related articles

Calcimimetics, like cinacalcet, target the calcium receptor to reduce parathyroid hormone secretion. This discovery offers valuable insights for developing new drugs and advancing medical research.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Drug Discovery

Background:

  • Calcimimetics are compounds that activate the calcium receptor.
  • Phenylalkylamines, such as cinacalcet, represent a key class of small molecule calcimimetics.
  • Cinacalcet is a selective positive allosteric modulator of the parathyroid calcium receptor.

Purpose of the Study:

  • To review the discovery of calcimimetics and their target receptor.
  • To extract lessons applicable to medical research and novel drug discovery.
  • To highlight the significance of cinacalcet in treating hyperparathyroidism.

Main Methods:

  • Literature review of calcimimetic research.
  • Analysis of cinacalcet's mechanism of action.
  • Examination of regulatory approval pathways for novel therapeutics.

Related Experiment Videos

Main Results:

  • Cinacalcet is the first approved calcimimetic for hyperparathyroidism in end-stage renal disease.
  • The study underscores the therapeutic potential of targeting the calcium receptor.
  • Understanding calcimimetic action provides a model for drug development.

Conclusions:

  • The development of calcimimetics demonstrates successful targeted drug discovery.
  • Lessons learned can inform future research into receptor modulators.
  • Further exploration of calcimimetic mechanisms may yield new therapeutic strategies.